S. 1522 · 118th Congress
A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.
- Stage
- In committee
- Sponsor
- Roger Marshall
- Introduced
- 2023-05-10
- Latest action
- 2023-05-10 · Introduced in Senate
Votes
No linked votes are available for this bill.